TGF-β1 enhances degradation of IFN-γ-induced iNOS protein via proteasomes in RAW 264.7 cells

Nitric Oxide - Biology and Chemistry

Volumn 13, Issue 1, 2005, Pages 78-87

  Mitani, Toshifumi ^a   Terashima, Masaharu ^a   Yoshimura, Hitoshi ^a   Nariai, Yuko ^a   Tanigawa, Yoshinori ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

IFN ; iNOS; Proteasome; RAW 264.7 cells; TGF 1

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHYMOTRYPSIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PEPTIDE; PROTEASOME; PROTEASOME INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; TRYPSIN; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; LEUPEPTIN; MULTIENZYME COMPLEX; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; UBIQUITINATION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MACROPHAGE; METABOLISM; TIME;

MURINAE;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERFERON TYPE II; LEUPEPTINS; MACROPHAGES; MICE; MULTIENZYME COMPLEXES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN;

EID: 20744453869     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.05.001     Document Type: Article

References (41)

1. G.S. Ashcroft Bidirectional regulation of macrophage function by TGF-β1 Microbes Infect. 1 1999 1275 1282
2. H. Mühl, and J. Pfeilschifter Anti-inflammatory properties and pro-inflammatory interferon-γ Int. Immunopharmacol. 3 2003 1247 1255
3. A.H. Klimp, E.G.E. de Vries, G.L. Scherphof, and T. Daemen A potential role of macrophage activation in the treatment of cancer Crit. Rev. Oncol. Hematol. 44 2002 143 161
4. Y. Vodovotz Control of nitric oxide production by transforming growth factor-β1: mechanistic insights and potential relevance to human disease Nitric Oxide 1 1997 3 17
5. F. Werner, M.K. Jain, M.W. Feinberg, N.E.S. Sibinga, A. Pellacani, P. Wieseli, M.T. Chin, J.N. Topper, M.A. Perrella, and M. Lee Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3 J. Biol. Chem. 275 2000 36653 36658
6. R.S. Gilbert, and H.R. Herschman Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types Biochem. Biophys. Res. Commun. 195 1993 380 384
7. Y. Vodovotz, C. Bogdan, J. Paik, Q.-W. Xie, and C. Nathan Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178 1993 605 613
8. M.W. Feinberg, M. Watanabe, M.A. Lebedeva, A.S. Depina, J. Hanai, T. Mammoto, J.P. Frederick, and X.-F. Wang Transforming growth factor-β1 inhibition of vascular smooth muscle cell activation is mediated via Smad3 J. Biol. Chem. 279 2004 16388 16393
9. R.K. Kutty, G. Kutty, J.J. Hooks, B. Wiggert, and C.N. Nagineni Transforming growth factor-β inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells Biochem. Biophys. Res. Commun. 215 1995 386 393
10. N.L. M-Francis, and S.M. Wahl Dysregulation of IFN-γ signaling pathway in the absence of TGF-β1 J. Immunol. 169 2002 5941 5947
11. Y. Vodovotz, A.G. Geiser, L. Chesler, J.J. Letterio, A. Cambell, S. Lucia, M.B. Sporn, and A.B. Roberts Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse J. Exp. Med. 183 1996 2337 2342
12. R.K. Assoian, B.E. Fleurdelys, and H.C. Stevenson Expression and secretion of type β transforming growth factor by activated macrophages Proc. Natl. Acad. Sci. USA 84 1987 6020 6024
13. D.R. Twardzik, J.A. Mikovits, J.E. Ranchalis, A.F. Ellingsworth, and F.W. Ruscetti Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes Ann. NY Acad. Sci. 593 1990 276 284
14. A. Ding, C.F. Nathan, J. Graycar, R. Derynck, D.J. Steher, and S. Srimal Macrophage deactivating factor and transforming growth factors-β1, -β2, and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ J. Immunol. 145 1990 940 944
15. B.J. Nelson, P. Ralph, S.J. Green, and C.A. Nacy Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-β1 J. Immunol. 146 1991 1849 1857
16. S.S. Gross, and M.S. Wolin Nitric oxide: pathophysiological mechanisms Annu. Rev. Physiol. 57 1995 737 769
17. C. Nathan Nitric oxide and nitric oxide synthase: what difference does it make? J. Clin. Invest. 100 1997 2417 2423
18. F.H. Guo, S.A.A. Comhair, S. Zheng, R.A. Dweik, N.T. Eissa, M.J. Thomassen, W. Calhoun, and S.C. Erzurum Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-transcriptional regulation of NO synthesis J. Immunol. 164 2000 5970 5980
19. M.A. Titheradge Nitric oxide in septic shock Biochim. Biophys. Acta 1411 1999 437 455
20. T.J. Guzik, R. Korbut, and T. Adamek-Guzik Nitric oxide and superoxide in inflammation and immune regulation J. Physiol. Pharmacol. 54 2003 469 487
21. R. Gyurko, G. Boustany, P.L. Huang, A. Kantarci, T.E.V. Dyke, C.A. Genko, and F.C. Gibson III Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis Infect. Immun. 71 2003 4917 4924
22. J.D. MacMicking, C. Nathan, G. Hom, N. Chartrain, D.S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hunchinson, H. Chen, and J.S. Mudgett Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 81 1995 641 650
23. A. Musial, and N. Eissa Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway J. Biol. Chem. 276 2001 24268 24273
24. P.J. Kolodziejski, A. Musial, J.-S. Koo, and N.T. Eissa Ubiquitination of inducible nitric oxide synthase is required for its degradation Proc. Natl. Acad. Sci. USA 99 2002 12315 12320
25. T. Nabika, M. Terashima, I. Momose, Y. Hosokawa, N. Nagasue, and Y. Tanigawa Synergistic effect of ubiquitin on lipopolysaccharide-induced TNF-α production in murine macrophage cell line RAW 264.7 cells Biochim. Biophys. Acta 1450 1999 25 34
26. 2+/calmodulin in RAW 264.7 cells Biochim. Biophys. Acta 1539 2001 101 113
27. T.P. Misko, R.J. Schilling, D. Salvemini, W.M. Moore, and M.G. Currie A fluorometric assay for the measurement of nitrite in biological samples Anal. Biochem. 214 1993 11 16
28. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
29. I. Momose, M. Terashima, Y. Nakashima, M. Sakamoto, H. Ishino, T. Nabika, Y. Hosokawa, and Y. Tanigawa Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-γ-treated RAW 264.7 cells Biochim. Biophys. Acta 1498 2000 19 31
30. A.J. Rivett, P.J. Savory, and H. Djaballah Multicatalytic endopeptidase complex: proteasome Methods Enzymol. 244 1994 331 350
31. J.E. Mullally, P.J. Moos, K. Edes, and F.A. Fitzpatrick Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway J. Biol. Chem. 276 2001 30366 30373
32. H. Ideguchi, A. Ueda, M. Tanaka, J. Yang, T. Tsuji, S. Ohno, E. Hagiwara, A. Aoki, and Y. Ishigatsubo Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM Biochem. J. 367 2002 87 95
33. K. Iwai, S.K. Drake, N.B. Wehra, A.M. Weissman, T. Lavaute, N. Minato, R.D. Klausner, R.L. Levine, and T.A. Rouault Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins Proc. Natl. Acad. Sci. USA 95 1998 4924 4928
34. T. Hattori, K. Kitagawa, C. Uchida, T. Oda, and M. Kitagawa Cksl is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner Genes Cells 8 2003 889 896
35. M. Orlowski, and S. Wilk Catalytic activities of 20S proteasome, a multicatalytic proteinase complex Arch. Biochem. Biophys. 383 2000 1 16
36. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-γ Annu. Rev. Immunol. 15 1997 749 795
37. S. Itoh, H. Itoh, M.-J. Goumans, and P. ten Dijke Signaling of transforming growth factor-β family members through Smad proteins Eur. J. Biochem. 267 2000 6954 6967
38. Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1 J. Biol. Chem. 274 1999 12197 12200
39. B. Boes, H. Hengel, T. Ruppert, G. Multhaup, U.H. Koszinowski, and P.M. Kloetzel Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes J. Exp. Med. 179 1994 901 909
40. S. Yamada, J. Yamada, K. Sato, T. Tokumoto, M. Yasutomi, and K. Ishikawa Irreversible potent activation and reversible inhibition of trypsin-like activity of 20S proteasome purified from Xenopus oocytes by fatty acid Zool. Sci. 15 1998 43 49
41. J.L. Reed, F.O. Dimayuga, L.M. Davies, J.N. Keller, and A.J. Bruce-Keller Estrogen increases proteasome activity in murine microglial cells Neurosci. Lett. 367 2004 60 65